Literature DB >> 8518699

Hepatitis C from immunoglobin infusions.

P S Lehner, A D Webster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8518699      PMCID： PMC1677976          DOI： 10.1136/bmj.306.6891.1541-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications.

Authors:  R A Hermaszewski; A D Webster
Journal:  Q J Med       Date:  1993-01

2.  Chronic liver disease due to hepatitis C.

Authors:  S Levi; C Foster; H J Hodgson; K N Ward; A So; J A Garson; J Waxman; D Swirsky
Journal:  BMJ       Date:  1993-04-17

3.  Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.

Authors:  J Björkander; C Cunningham-Rundles; P Lundin; R Olsson; R Söderström; L A Hanson
Journal:  Am J Med       Date:  1988-01       Impact factor: 4.965
  3 in total
  4 in total

Review 1.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

2.  Efficacy and tolerability of an argentine intravenous immunoglobulin in pediatric patients with primary immunodeficiency diseases.

Authors:  S Krasovec; A Ornani; M Oleastro; S Rosenzweig; A Roy; L Perez; G Campos; N Marín; A Martinez; C Mahieu; M J Manfredi; A Sisti; M Zelazko
Journal:  J Clin Immunol       Date:  2007-01-19       Impact factor: 8.317

Review 3.  Hepatitis C: progress and problems.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

4.  Safety, efficacy, and pharmacokinetics of Flebogamma 5% [immune globulin intravenous (human)] for replacement therapy in primary immunodeficiency diseases.

Authors:  Melvin Berger; Paul J Pinciaro
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.